Latest Institutional Placement News

Saunders International has agreed to acquire Aqua Metro for up to $30 million, marking a strategic push into water infrastructure with strong financial prospects and a robust project pipeline.

FireFly Metals has doubled its Share Purchase Plan to A$10 million following overwhelming demand, boosting its cash position to approximately A$145 million to accelerate drilling and mining studies at its Green Bay Copper-Gold Project.

ikeGPS Group Limited has announced a fully underwritten A$18 million placement and a A$2 million share purchase plan to fund new product development and expand its market leadership in North America's utility software sector.

Blackstone Minerals has launched a $2 million Share Purchase Plan at a 9% discount, running alongside a $22.6 million placement to institutional investors. Eligible shareholders in Australia and New Zealand can buy shares up to $30,000, supporting the company’s Mankayan Copper-Gold Project expansion.

BetMakers Technology Group has successfully closed an oversubscribed Share Purchase Plan, boosting its total capital raise to $13.7 million alongside a recent placement. The funds will support debt repayment, strategic acquisitions, and operational growth.

Antipa Minerals has raised A$40 million through a strategic placement to accelerate development and resource expansion at its Minyari Gold-Copper Project in Western Australia. This capital boost, combined with existing funds, positions the company to deliver key feasibility studies and advance drilling programs.

Vitasora Health has secured approximately A$11 million in capital to accelerate its expansion in the US remote patient monitoring market, highlighted by an upgraded contract with TPAC covering 15,000 patients. The company targets a USD 18 million annual recurring revenue run-rate by late 2026.

Microba Life Sciences invites eligible shareholders to participate in a $2 million Share Purchase Plan at $0.09 per share, matching recent institutional pricing and including free attaching options. The capital raise aims to accelerate clinical adoption and push the company towards regional break-even.

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart stem cell technology, setting the stage for a focused clinical push in treating fistulising Crohn’s disease. The company also refreshed its board and raised $7.5 million to support this next phase.

Duxton Farms announces a transformative merger with four private agricultural companies, alongside a $4 million fully underwritten placement and a special dividend, aiming to significantly expand its asset base and diversify its portfolio.

MTM Critical Metals has raised A$50 million through a well-supported institutional placement to accelerate the rollout of its proprietary Flash Joule Heating technology in the U.S. This capital injection marks a pivotal step in MTM’s transformation into a U.S.-focused clean technology company.

Xero has completed a significant A$1.85 billion institutional placement to fund its acquisition of Melio, aiming to enhance its accounting and payments platform in the US market. A complementary A$200 million Share Purchase Plan will offer retail investors a chance to participate.